
    
      Patients received curative BTC surgery will be informed about the study. After being informed
      about the study and potential risks, all patients giving written informed consent will
      undergo a 1-week screening period to determine eligibility for study entry. At week 0,
      patients who meet the eligibility requirements will be observed for recurrence of BTC.
    
  